XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
4 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]    
REVENUES $ 904 $ 904
RESEARCH AND DEVELOPMENT EXPENSES 9,037 6,889
SALES AND MARKETING EXPENSES 898
GENERAL AND ADMINISTRATIVE EXPENSES 3,295 1,576
OPERATING LOSS 12,326 7,561
FINANCIAL INCOME (158) (260)
FINANCIAL EXPENSES 87 23
NET LOSS FOR THE PERIOD 12,255 7,324
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS 587
NET LOSS ATTRIBUTABLE TO STOCKHOLDERS $ 11,668 $ 7,324
LOSS PER SHARE    
BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK (in Dollars per share) $ 0.31 $ 0.3
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK (in Shares) 37,113,137 24,394,010